{"uri": "eng-9429901", "concepts": [{"uri": "http://en.wikipedia.org/wiki/Oncology", "type": "wiki", "score": 100, "label": {"eng": "Oncology"}}, {"uri": "http://en.wikipedia.org/wiki/Biopharmaceutical", "type": "wiki", "score": 81, "label": {"eng": "Biopharmaceutical"}}, {"uri": "http://en.wikipedia.org/wiki/Shareholder", "type": "wiki", "score": 76, "label": {"eng": "Shareholder"}}, {"uri": "http://en.wikipedia.org/wiki/Cancer", "type": "wiki", "score": 56, "label": {"eng": "Cancer"}}, {"uri": "http://en.wikipedia.org/wiki/Chief_executive_officer", "type": "wiki", "score": 50, "label": {"eng": "Chief executive officer"}}, {"uri": "http://en.wikipedia.org/wiki/Enzyme_inhibitor", "type": "wiki", "score": 39, "label": {"eng": "Enzyme inhibitor"}}, {"uri": "http://en.wikipedia.org/wiki/Doctor_of_Medicine", "type": "wiki", "score": 39, "label": {"eng": "Doctor of Medicine"}}, {"uri": "http://en.wikipedia.org/wiki/New_York_Stock_Exchange", "type": "wiki", "score": 36, "label": {"eng": "New York Stock Exchange"}}, {"uri": "http://en.wikipedia.org/wiki/ROS1", "type": "wiki", "score": 35, "label": {"eng": "ROS1"}}, {"uri": "http://en.wikipedia.org/wiki/Board_of_directors", "type": "wiki", "score": 29, "label": {"eng": "Board of directors"}}, {"uri": "http://en.wikipedia.org/wiki/Market_capitalization", "type": "wiki", "score": 29, "label": {"eng": "Market capitalization"}}, {"uri": "http://en.wikipedia.org/wiki/United_States", "type": "loc", "score": 25, "label": {"eng": "United States"}, "location": {"type": "country", "label": {"eng": "United States"}}}, {"uri": "http://en.wikipedia.org/wiki/China", "type": "loc", "score": 24, "label": {"eng": "China"}, "location": {"type": "country", "label": {"eng": "China"}}}, {"uri": "http://en.wikipedia.org/wiki/New_drug_application", "type": "wiki", "score": 22, "label": {"eng": "New drug application"}}, {"uri": "http://en.wikipedia.org/wiki/Priority_review", "type": "wiki", "score": 15, "label": {"eng": "Priority review"}}, {"uri": "http://en.wikipedia.org/wiki/Food_and_Drug_Administration", "type": "wiki", "score": 15, "label": {"eng": "Food and Drug Administration"}}], "eventDate": "2024-03-25", "totalArticleCount": 11, "title": {"eng": "Nuvation Bio to acquire AnHeart in all-stock deal By Investing.com"}, "summary": {"eng": "NEW YORK - Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company focused on developing therapies for oncology, has announced a definitive agreement to acquire AnHeart Therapeutics Ltd., a clinical-stage biopharmaceutical company. The all-stock transaction will see AnHeart's shareholders owning approximately 33% of the combined entity, with Nuvation Bio's current stockholders owning around 67%.\n\nThe acquisition, expected to close in the second quarter of 2024, aims to transform Nuvation Bio "}, "location": null, "categories": [{"uri": "dmoz/Business/Biotechnology_and_Pharmaceuticals/Pharmaceuticals", "label": "dmoz/Business/Biotechnology and Pharmaceuticals/Pharmaceuticals", "wgt": 100}, {"uri": "dmoz/Business/Healthcare/Marketing_and_Advertising", "label": "dmoz/Business/Healthcare/Marketing and Advertising", "wgt": 100}, {"uri": "dmoz/Business/Biotechnology_and_Pharmaceuticals/Consulting", "label": "dmoz/Business/Biotechnology and Pharmaceuticals/Consulting", "wgt": 100}, {"uri": "news/Business", "label": "news/Business", "wgt": 87}], "articleCounts": {"eng": 11}, "sentiment": 0.3411764705882352, "wgt": 449020800, "relevance": 2}